Dementia news: the antidepressant Mirtazapine (Remeron) is prescribed to treat agitation in individuals with dementia. However, a new study has shown that it is no more effective than a placebo, and it may be more associated with mortality than no treatment.

You should never take medical advice from social media, especially from someone who is not a medical doctor (aka, me). I am just providing this information for individuals who want to learn more about new frontiers in the treatment of dementia.

reference: Banerjee, S., et al. (2021). Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. The Lancet, 398.